Asie · Presse financière · The Economic Times

Moderna Stock Selloff: Why positive cancer vaccine results failed to lift shares

Publié par The Economic Times · Inde il y a 1 h

Moderna shares plunged after detailed cancer vaccine trial results triggered profit-taking despite reducing melanoma recurrence risk by 42%. Investors weigh commercial prospects,…

Lire l'article complet sur The Economic Times Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (economictimes.indiatimes.com)

Moderna Stock Selloff: Why positive cancer vaccine results failed to lift shares

À lire aussi

Market sell-off, tax scrutiny and growth: key figures shaping investor sentiment

In Depth: China’s Offshore Trust Tax Grace Period Ends as Questions Linger

Chinese stocks fight economic gloom after slide into bear territory

Moderna Stock Selloff: Why positive cancer vaccine results failed to lift shares

Partager

À lire aussi

Market sell-off, tax scrutiny and growth: key figures shaping investor sentiment

In Depth: China’s Offshore Trust Tax Grace Period Ends as Questions Linger

Chinese stocks fight economic gloom after slide into bear territory